ESPEN Guidelines on Parenteral Nutrition: home parenteral nutrition (HPN) in adult patients.
Home parenteral nutrition (HPN) was introduced as a treatment modality in the early 1970s primarily for the treatment of chronic intestinal failure in patients with benign disease. The relatively low morbidity and mortality associated with HPN has encouraged its widespread use in western countries. Thus there is huge clinical experience, but there are still few controlled clinical studies of treatment effects and management of complications. The purpose of these guidelines is to highlight areas of good practice and promote the use of standardized treatment protocols between centers. The guidelines may serve as a framework for development of policies and procedures.
Staun
Michael
M
Department of Medical Gastroenterology, Rigshospitalet, Copenhagen, Denmark.
Pironi
Loris
L
Bozzetti
Federico
F
Baxter
Janet
J
Forbes
Alastair
A
Joly
Francesca
F
Jeppesen
Palle
P
Moreno
Jose
J
Hébuterne
Xavier
X
Pertkiewicz
Marek
M
Mühlebach
Stefan
S
Shenkin
Alan
A
Van Gossum
André
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001851:Bone Diseases, Metabolic / Q000517:prevention & control; D004750:Enteral Nutrition; D019317:Evidence-Based Medicine; D006699:Home Care Services / Q000592:standards; D006801:Humans; D008107:Liver Diseases / Q000628:therapy; D044342:Malnutrition / Q000628:therapy*; D008875:Middle Aged; D009752:Nutritional Status; D016331:Parenteral Nutrition, Home / Q000009:adverse effects / Q000592:standards; D010348:Patient Care Team; D011788:Quality of Life; D016896:Treatment Outcome; D055815:Young Adult